Dimension Secures $500M to Fund Biotech-Tech Convergence (Health & Beauty - Health Services)

Hot-Web-Ads > Health & Beauty > Health Services

Item ID 16113135 in Category: Health & Beauty - Health Services

Dimension Secures $500M to Fund Biotech-Tech Convergence


Dimension, a biotech venture firm founded by former Lux Capital and Obvious Ventures investors, has raised its second fund, Dimension II, which totals $500 million, surpassing the $350 million raised in its first fund in January 2023. The firm’s focus remains on companies at the intersection of life sciences and technology, particularly those developing tech-powered therapeutics and tools to enhance drug discovery and manufacturing.

Dimension plans to make around 24 investments with this fund, ranging from single-digit millions to over $40 million. The investments will span new startups, growing companies, and publicly traded biotechs. Co-founders Adam Goulburn, Zavain Dar, and Nan Li emphasize their “contrarian” approach, which combines life sciences expertise with computing knowledge to reflect the modern biotech landscape. Their portfolio includes drug discovery companies like Chai Discovery and Kimia Therapeutics, as well as software-focused firms like Automata and Kaleidoscope Bio, aimed at optimizing drugmaking processes.

For more details please visit our website - https://www.medhealthinsight.com/dimension-secures-500m-to-fund-biotech-tech-convergence/


Related Link: Click here to visit item owner's website (0 hit)

Target State: New York
Target City : New York City
Last Update : Jul 16, 2025 3:17 AM
Number of Views: 20
Item  Owner  : medhealthinsight
Contact Email: (None)
Contact Phone: (None)

Friendly reminder: Click here to read some tips.
Hot-Web-Ads > Health & Beauty > Health Services
 © 2025 Hot-Web-Ads.com
2025-08-04 (1.067 sec)